Completed OBSERVATIONAL NCT00216801

Relationship of Ochratoxin A to Upper Urologic Cancers

The Relationship of Ochratoxin A to Upper Tract TCC Malignancies, Testicular Cancer, and Renal Cell Cancer

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Conditions Renal Cell Cancer Testicular Cancer Transitional Cell Carcinoma

Updated 8 times since 2017 Last updated: Jan 20, 2009 Started: Sep 30, 2005 Primary completion: Apr 30, 2007 Completion: Apr 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Renal Cell Cancer and Testicular Cancer and is currently completed. London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's leads this study, which shows 8 recorded versions since 2005 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

8 versions recorded

Apr 2025 — Present [monthly]

Completed
Jan 2025 — Apr 2025 [monthly]

Completed
Sep 2024 — Jan 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Sep 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Data source: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, Canada